CompoAtlas

Aliacin Super

Natural health product licensed in Canada

Licence holder
Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
NPN or DIN-HM
80009324
Status
Inactive licence
Licence date
8 February 2009
Revision date
9 May 2018
Form
Comprimé entéro-soluble
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Allium sativum

Source : Bulbe

Potency : 0.4 % Allicine

300 mgNot calculated

Non-medicinal ingredients

Calcium phosphate, Copolymère d'acide méthacrylique, Talc, Cellulose, microcristalline, Hydroxypropylcellulose, Citrate de triéthyle, Gel de silice, Stéarate de magnésium, simethicone, Macrogol 400

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Comprimé ; maximum: 3 CompriméNot specified

Uses authorised in Canada

Utilisé traditionnellement en phytothérapie pour aider à soulager les symptômes liés aux infections des voies respiratoires supérieures et aux affections catarrhales. Utilisé en phytothérapie pour aider à diminuer les taux élevés de lipides sanguins/hyperlipidémie chez les adultes. Utilisé en phytothérapie pour aider au maintien de la santé cadiovasculaire chez les adultes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80009324

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line